World's Best Scientists 2026 revealed!
Yoshihiko Maehara

Yoshihiko Maehara

Award Badge
Medicine
Japan
2023

D-Index & Metrics

Medicine

D-Index
122
Citations
66747
World Ranking
3429
National Ranking
64

Yoshihiko Maehara publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Yoshihiko Maehara sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 2,121 publications — 100th percentile

100% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Yoshihiko Maehara D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Yoshihiko Maehara sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 122 D-Index — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2023 - Research.com Medicine in Japan Leader Award

Overview

Yoshihiko Maehara is affiliated with Kyushu University in Japan and has contributed extensively to the field of medicine, with a particular focus on oncology. Their research portfolio spans 95 publications related to medicine, with significant emphasis on subfields including oncology, pulmonary and respiratory medicine, surgery, molecular biology, and hepatology.

Their research interests cover various topics, notably:

  • Colorectal Cancer Treatments and Studies
  • Gastric Cancer Management and Outcomes
  • Genetic factors in colorectal cancer
  • Colorectal Cancer Surgical Treatments
  • Lung Cancer Treatments and Mutations
  • Cancer Immunotherapy and Biomarkers
  • Cancer Cells and Metastasis

Yoshihiko Maehara has published papers in several frequent venues, including:

  • International Journal of Clinical Oncology
  • Annals of Oncology
  • ESMO Open
  • Gastric Cancer
  • Molecular Cancer Research

Among the recent papers associated with their research are:

  • "Oxaliplatin-based adjuvant chemotherapy duration (3 versus 6 months) for high-risk stage II colon cancer: the randomized phase III ACHIEVE-2 trial" (2020, Annals of Oncology)
  • "Gut microbiota diversity and specific composition during immunotherapy in responders with non-small cell lung cancer" (2022, Frontiers in Molecular Biosciences)
  • "Direct reprogramming of human umbilical vein- and peripheral blood-derived endothelial cells into hepatic progenitor cells" (2020, Nature Communications)
  • "Trifluridine/tipiracil plus bevacizumab as a first-line treatment for elderly patients with metastatic colorectal cancer (KSCC1602): A multicenter phase II trial" (2020, Cancer Medicine)
  • "First Observation of Electron Scattering from Online-Produced Radioactive Target" (2023, Physical Review Letters)

Their frequent co-authors include:

  • Eiji Oki
  • Koji Ando
  • Masaki Mori
  • Hiroyuki Kitao
  • Akitaka Makiyama

Best Publications

  • A gp130-Src-YAP Module Links Inflammation to Epithelial Regeneration

    Koji Taniguchi;Koji Taniguchi;Koji Taniguchi;Li Wha Wu;Li Wha Wu;Sergei I. Grivennikov;Sergei I. Grivennikov;Petrus R. De Jong

  • Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma

    N. Harimoto;K. Shirabe;Y. I. Yamashita;Toru Ikegami

  • Neutrophil–lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment

    Takashi Motomura;Ken Shirabe;Yohei Mano;Jun Muto

  • Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: a retrospective analysis.

    Yohei Mano;Ken Shirabe;Yo Ichi Yamashita;Norifumi Harimoto

  • Dysregulation of PRMT1 and PRMT6, Type I arginine methyltransferases, is involved in various types of human cancers

    Masanori Yoshimatsu;Gouji Toyokawa;Shinya Hayami;Motoko Unoki

  • Clinical significance of occult micrometastasis in lymph nodes from patients with early gastric cancer who died of recurrence

    Yoshihiko Maehara;Tatsuo Oshiro;Kazuya Endo;Hideo Baba

  • Sarcopenia is a prognostic factor in living donor liver transplantation

    Toshiro Masuda;Ken Shirabe;Toru Ikegami;Norifumi Harimoto

  • Epithelial to mesenchymal transition in an epidermal growth factor receptor-mutant lung cancer cell line with acquired resistance to erlotinib.

    Kenichi Suda;Kenji Tomizawa;Makiko Fujii;Hideki Murakami

  • Identification of a bona fide microRNA biomarker in serum exosomes that predicts hepatocellular carcinoma recurrence after liver transplantation

    K Sugimachi;T Matsumura;H Hirata;R Uchi

  • Colorectal cancer screening with odour material by canine scent detection

    Hideto Sonoda;Shunji Kohnoe;Shunji Kohnoe;Tetsuro Yamazato;Yuji Satoh

  • Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population.

    Minoru Nakamura;Nao Nishida;Minae Kawashima;Yoshihiro Aiba

  • Reciprocal and Complementary Role of MET Amplification and EGFR T790M Mutation in Acquired Resistance to Kinase Inhibitors in Lung Cancer

    Kenichi Suda;Isao Murakami;Tatsuya Katayama;Kenji Tomizawa

  • Deregulation of the Akt pathway in human cancer.

    Eriko Tokunaga;Eiji Oki;Akinori Egashira;Noriaki Sadanaga

  • Long-term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi-institutional Japanese study.

    Takeshi Takahara;Go Wakabayashi;Toru Beppu;Arihiro Aihara

  • Complications and diagnosis of Meckel's diverticulum in 776 patients.

    Hiroki Kusumoto;Motofumi Yoshida;Ikuo Takahashi;Hideaki Anai

  • Lymph-node metastases: efficacy for detection with helical CT in patients with gastric cancer.

    Tatsuro Fukuya;Hiroshi Honda;Takamoto Hayashi;Kuniyuki Kaneko

  • Deletion of the SOCS3 gene in liver parenchymal cells promotes hepatitis-induced hepatocarcinogenesis.

    Hisanobu Ogata;Takashi Kobayashi;Takatoshi Chinen;Hiromi Takaki

  • Vascular invasion and potential for tumor angiogenesis and metastasis in gastric carcinoma.

    Yoshihiko Maehara;Akira Kabashima;Tadashi Koga;Eriko Tokunaga

  • Variants in IL28B in liver recipients and donors correlate with response to peg-interferon and ribavirin therapy for recurrent hepatitis C.

    Takasuke Fukuhara;Akinobu Taketomi;Takashi Motomura;Shinji Okano

  • Overexpression of the MTA1 gene in gastrointestinal carcinomas: Correlation with invasion and metastasis

    Yasushi Toh;Eiji Oki;Shinya Oda;Eriko Tokunaga

Frequent Co-Authors

Ken Shirabe
Ken Shirabe Gunma University
Akinobu Taketomi
Akinobu Taketomi Hokkaido University
Keizo Sugimachi
Keizo Sugimachi Kyushu University
Hideo Baba
Hideo Baba Kumamoto University
Yoshinao Oda
Yoshinao Oda Kyushu University
Mitsuo Shimada
Mitsuo Shimada University of Tokushima
Masaki Mori
Masaki Mori Kyushu University
Koshi Mimori
Koshi Mimori Kyushu University
Shoji Natsugoe
Shoji Natsugoe Kagoshima University
Masazumi Tsuneyoshi
Masazumi Tsuneyoshi Kyushu University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring careers in medicine goes beyond becoming a physician. Today, students have multiple online degree options that can complement or pave alternative paths in healthcare. For registered nurses, asn to np programs offer a flexible route from an associate degree in nursing to advanced nurse practitioner roles. These programs are ideal for those wanting to expand their clinical scope while maintaining work commitments.

If you’re interested in nutrition science, pursuing online degrees in nutrition can open doors to careers in dietetics, wellness coaching, and public health. Many programs are designed for online learning, making them accessible and accommodating for diverse lifestyles.

Leadership-minded professionals may consider a cahme accredited online mha to prepare for roles in healthcare management and administration. These accredited programs ensure quality education and can lead to high-growth careers in hospital and health system leadership.

For RNs looking to advance without extensive clinical requirements, there are reputable rn to bsn programs no clinicals that streamline the path to a bachelor’s degree. These online pathways provide advancement opportunities while accommodating full-time work schedules.

Best Scientists Citing Yoshihiko Maehara

Trending Scientists

Recently Published Articles